October 31, 2019

8:30 – 9:00am

Registration & Networking

9:00 – 9:10am

Welcome & Opening Remarks

9:10 – 9:40am

UCSD, New Companies & the Local Innovation Ecosystem:
What Are We Seeing that Works?

Chris Loryman – Senior Manager of Innovation and Commercialization, UCSD

9:40 – 10:20am

Early Developability Assessment Tools:
Successful De-risking Strategies to Support Progression of Biologics from Discovery to Development  

Yvette Stallwood – Head of Applied Protein Services, Lonza

10:20 – 10:50am

Moving Antibody-Oligonucleotide Conjugates (AOCs) Into Development

Andy Geall – Vice President of Formulations, Analytics and Chemistry, Avidity Biosciences

10:50 – 11:10am

Coffee Networking Break

11:10 – 11:50am

Overview and Recent Enhancements to the Lonza GS Xceed® Toolbox:
New Approaches to Address Complex Proteins

Andy Racher – Director of R&D, Lonza

11:50am – 12:30pm

Developing Cell Lines and Processes for Manufacturing Protein Therapeutics:
Who Wins – the Hare, the Tortoise, or a Hybrid?

Alison Porter – Head of Expression System Sciences, Lonza

12:30 – 1:30pm

Networking Lunch

1:30 – 3:30pm

Drop-in Clinic Sessions / Additional Presentations

Meet Lonza specialists during pre-booked, 1-on-1 sessions:

  • Yvette Stallwood – De-risking biotherapeutic candidates
  • Alison Porter – Expression of complex proteins
  • Andy Racher – Cell lines & processes for biotherapeutics
  • Jagruti Patel – Program planning
  • Chris Loryman – UCSD innovation & commercialization
  • Commercial discussions

A parallel session features presentations from startup companies and leading academics (lineup TBD).

Please note that this schedule is subject to change.